Soni Medicare Ltd. FY26 Results: Revenue Dips, Net Loss Widens

Soni Medicare Ltd. reported a net loss of ₹2.71 crore for the fiscal year ended March 31, 2026, compared to a net loss of ₹0.19 crore in the previous fiscal year.

Reader Takeaway: Declining revenue and increasing losses highlight significant financial stress, though management maintains a going concern assumption.

What just happened

Soni Medicare Ltd. announced its financial results for the fiscal year ended March 31, 2026. The company posted a revenue from operations of ₹24.71 crore, a 17.2% decrease from ₹29.84 crore in FY25. The net loss for the fiscal year widened to ₹2.71 crore from ₹0.19 crore in the prior year. Basic earnings per share (EPS) stood at ₹(5.94) for FY26, down from ₹(0.74) in FY25.

Operating cash flow also turned negative, recording a net cash outflow of ₹0.26 crore in FY26, a reversal from a positive cash inflow of ₹1.54 crore in FY25. The company's 'Skill Institute' operations were deemed immaterial and have been consolidated into the 'Healthcare Facilities' segment, making it the sole reportable segment.

Why this matters

This financial performance indicates significant operational challenges for Soni Medicare. The decline in revenue and widening net loss suggest a contraction in the company's core business and a deterioration in profitability. The negative operating cash flow raises concerns about liquidity and the ability to fund operations from its core business activities. An increase in trade receivables to ₹12.75 crore from ₹8.76 crore could signal potential working capital management or collection issues.

The backstory

In the previous fiscal year (FY25), Soni Medicare had reported revenue of ₹29.84 crore and a net loss of ₹0.19 crore. The auditor provided an unmodified opinion for the FY26 financial statements, suggesting no major issues with accounting practices. The company has reassessed its operating segments, consolidating 'Skill Institute' operations into 'Healthcare Facilities' due to non-materiality.

What changes now

For investors, the immediate implication is a need for closer scrutiny of the company's financial health. The shift to a single reportable segment simplifies reporting but does not alter the underlying performance concerns. Management's assumption of a 'going concern' indicates their belief in the company's ability to continue operations, but this needs to be supported by improved financial metrics.

Risks to watch

The primary risks revolve around the company's profitability, liquidity, and working capital management. The increasing net loss and negative operating cash flow require immediate attention. Furthermore, the rise in trade receivables could indicate challenges in collecting payments from customers, potentially impacting cash availability.

Context metrics (time-bound)

• Revenue (FY26): ₹24.71 crore (down 17.2% from FY25)
• Net Loss (FY26): ₹2.71 crore (widened from ₹0.19 crore in FY25)
• Operating Cash Flow (FY26): ₹(0.26) crore (negative, compared to ₹1.54 crore in FY25)
• Trade Receivables (FY26): ₹12.75 crore (up from ₹8.76 crore in FY25)

What to track next

Investors should closely monitor Soni Medicare's future quarterly results to see if revenue trends reverse and if losses begin to narrow. The management of trade receivables and overall working capital efficiency will be crucial indicators of operational improvement. The company's ability to generate positive cash flows from operations will be a key factor for its sustainability.